Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled

Anna R. Hemnes, Marc Humbert

Source: Eur Respir Rev, 26 (146) 170093; 10.1183/16000617.0093-2017
Journal Issue: October
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anna R. Hemnes, Marc Humbert. Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled. Eur Respir Rev, 26 (146) 170093; 10.1183/16000617.0093-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010


COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020



Inflammation in pulmonary arterial hypertension: is it time to quell the fire?
Source: Eur Respir J 2014; 43: 685-688
Year: 2014


Pathobiology of pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Pathobiology of pulmonary hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012


Pathobiology of pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

Pathobiology of pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Genetics and genomics of pulmonary arterial hypertension
Source: Eur Respir J, 53 (1) 1801899; 10.1183/13993003.01899-2018
Year: 2019



The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



The revolution of pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 361-363
Year: 2016


Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021
Year: 2021



The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005

The challenges in paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 498-504
Year: 2014



Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003



Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014



Optimising the management of pulmonary arterial hypertension patients: emergency treatments
Source: Eur Respir Rev 2010 19: 204-211
Year: 2010



Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018